HanAll Biopharma Information
Contact top employees from
HanAll Biopharma
Summary
HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with a presence in Korea, the USA, Japan, and Indonesia, with a mission to make meaningful contributions to patients' lives by i...Show more
Industries
Biotechnology
Headquarters Location
Employees Size
200-500 employees
Specialties
Innovation, Novel biologic drugs, R&D
Founded
1973
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at HanAll Biopharma shows a diverse range of experience levels:
7% have been with the company for less than 1 year10% for 1–2 years7% for 3–4 years10% for 5–7 years10% for 8–10 years57% have over 11 years of service at HanAll BiopharmaContact top employees from
HanAll Biopharma
Kristin Wilborn
Director of Biostatistics
Andria White
Senior Manager, Clinical Operations
Geralyn Angeles
Chief of Staff
Mary Bearkland
Sr. Director Clinical Operations
Sungwook Choi
Principal Scientist
Nayaki Muthusamy
Program Lead
Fawn Chromik
Sr. Director Clinical Operations
Youngweon Lee
Associate
Joanne Lee
General Operations Manager
David Hernandez
Vice President, Head of Clinical Development Operations
Ann Joohyun
Program Manager, Clinical Operations & Strategy, HPI INC.
Sean Jeong
President and CEO
Siti Kerinciwati
Executive Assistant
Soraya Nabila Arifa
Associate Director
Alifia Salsabila
Medical Doctor Associate
Rida Sieseria Ramadhani
Research Fellow
Tamarachiara
Research Fellowship
Muhammad Fahmi
Medical Doctor
Anggita Nur Widya Febriana
Research Fellow
Ria Lupitasari
Research Fellow
Youngju Kim
Director of Global Research Center
Arlin Dhica Cahya
Research Fellow
Olivia Indira Sofyan
Research Fellowship
Hyo Min Kim
Senior Scientist, HPI Inc.
Jimin Hwang
Public Relations Manager
Similar Companies
FAQ
HanAll Biopharma operates in the Biotechnology industries. More details can be found on the official website: hanall.com.
The headquarters of HanAll Biopharma are located in Seoul, Republic of Korea.
HanAll Biopharma currently employs 200-500 people.
